Patents

Biophan files drug delivery patent for use of NaturalNano's Halloysite nanotubes

Published in Drug Week, June 9th, 2006

Biophan Technologies, Inc., (BIPH, BTN), a developer of next-generation medical technology, announced that it has filed a U.S. patent application for the use of halloysite nanotubes for controlled release of drugs.

The technology utilizes halloysite nanotubes, which are being commercialized by NaturalNano, Inc., (NNAN, N3N). These nanotubes, which are hollow inorganic nanostructures derived from clay, allow the linear, controlled release of drugs. "In addition, the nanochopping technology being developed allows for achieving precisely defined sizes of nanotubes to ensure the predictable performance and dosing required for a given drug," stated Stephen Curry, president...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2006-06-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry